Elicera To Advance Next-Gen Cell Therapies Following IPO

Interview With CEO Jamal El-Mosleh

 
• By William Masters
  
ELICERA HAS TWO CAR-T AND TWO ONCOLYTIC VIRUS CANDIDATES • Source: Alamy
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from In Vivo